Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Integer Holdings Corp (ITGR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/10/2025: ITGR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $148.75
1 Year Target Price $148.75
| 7 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 23.8% | Avg. Invested days 76 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 07/10/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.20B USD | Price to earnings Ratio 56.29 | 1Y Target Price 148.75 |
Price to earnings Ratio 56.29 | 1Y Target Price 148.75 | ||
Volume (30-day avg) 10 | Beta 0.98 | 52 Weeks Range 104.93 - 146.36 | Updated Date 07/10/2025 |
52 Weeks Range 104.93 - 146.36 | Updated Date 07/10/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.14 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.4% | Operating Margin (TTM) 12.67% |
Management Effectiveness
Return on Assets (TTM) 4.51% | Return on Equity (TTM) 4.98% |
Valuation
Trailing PE 56.29 | Forward PE 21.55 | Enterprise Value 5526336637 | Price to Sales(TTM) 2.41 |
Enterprise Value 5526336637 | Price to Sales(TTM) 2.41 | ||
Enterprise Value to Revenue 3.16 | Enterprise Value to EBITDA 19.98 | Shares Outstanding 34892000 | Shares Floating 34498413 |
Shares Outstanding 34892000 | Shares Floating 34498413 | ||
Percent Insiders 0.89 | Percent Institutions 116.4 |
Upturn AI SWOT
Integer Holdings Corp
Company Overview
History and Background
Integer Holdings Corp. (formerly Greatbatch) was founded in 1970. Initially focused on battery technology for cardiac pacemakers, it has evolved into a major medical device outsource manufacturer, providing design, development, and manufacturing services for a wide range of medical devices and components.
Core Business Areas
- Medical: Manufactures and develops medical devices and components, including pacing, neuromodulation, vascular, cardiac rhythm management, and orthopedic applications.
- Advanced Surgical & Specialty: Focuses on advanced surgical and specialty medical applications.
Leadership and Structure
The leadership team includes Payman Khales, President & CEO. The company has a typical corporate structure with various departments including operations, finance, sales, and marketing.
Top Products and Market Share
Key Offerings
- Cardiac Rhythm Management (CRM) Devices & Components: Integer provides components and finished devices for cardiac rhythm management, competing with Medtronic (MDT), Abbott (ABT), and Boston Scientific (BSX). Estimated Market Share Data can vary due to being components and finished devices, difficult to accurately define.
- Neuromodulation Devices & Components: Integer manufactures components used in neuromodulation therapies for pain management and neurological disorders, competing with Medtronic (MDT), Boston Scientific (BSX), and Abbott (ABT). Estimated Market Share Data can vary due to being components and finished devices, difficult to accurately define.
- Vascular Devices & Components: Integer develops components for vascular medical devices and is competing against Medtronic (MDT) and Boston Scientific (BSX). Estimated Market Share Data can vary due to being components and finished devices, difficult to accurately define.
Market Dynamics
Industry Overview
The medical device industry is experiencing steady growth driven by an aging population, increasing prevalence of chronic diseases, and technological advancements. Stringent regulatory requirements and competitive pricing pressures are significant factors.
Positioning
Integer is positioned as a leading medical device outsource manufacturer (MDOM) and component supplier. Its competitive advantage lies in its technical expertise, manufacturing capabilities, and long-standing relationships with major medical device companies.
Total Addressable Market (TAM)
The total addressable market for medical device outsourcing is estimated to be in the tens of billions of dollars annually. Integer is positioned well to capture a significant portion of this TAM through its focus on high-growth medical device segments.
Upturn SWOT Analysis
Strengths
- Strong technical expertise in medical device manufacturing
- Established relationships with leading medical device companies
- Diverse product portfolio
- Global manufacturing footprint
- Strong IP position
Weaknesses
- Customer concentration
- Dependence on key suppliers
- Vulnerable to changing regulatory landscape
- Limited brand recognition with end consumers
- Slower growth compared to some competitors
Opportunities
- Expanding into new geographic markets
- Developing new technologies and products
- Acquiring complementary businesses
- Benefiting from increasing demand for outsourced medical device manufacturing
- Penetrating high-growth medical device segments such as robotics
Threats
- Intense competition from other medical device manufacturers
- Pricing pressures from customers
- Changes in regulatory requirements
- Economic downturn
- Product liability risks
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Boston Scientific (BSX)
- Abbott (ABT)
Competitive Landscape
Integer competes with major medical device OEMs as well as other contract manufacturers. Integer differentiates itself through its technical expertise, focus on complex devices, and vertically integrated manufacturing capabilities.
Major Acquisitions
Lake Region Medical
- Year: 2015
- Acquisition Price (USD millions): 1725
- Strategic Rationale: Expanded product portfolio and increased scale in the medical device market.
Oscor
- Year: 2016
- Acquisition Price (USD millions): 193
- Strategic Rationale: Expanded offerings of specialized delivery systems and lead technologies.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data requires specific financial data. Consult Integer Holdings Corp's SEC filings.
Future Projections: Future growth projections require analyst estimates. Consult financial data providers for this information.
Recent Initiatives: Recent initiatives involve strategic acquisitions, facility expansion, and new product development to accelerate growth and strengthen market position.
Summary
Integer Holdings Corp. is a significant player in the medical device outsourcing market, leveraged to the medical device industry but not as large as its peers. Their core strength lies in complex medical devices and contract manufacturing. Key challenges include competition from larger players and vulnerability to industry regulations. Recent acquisitions and initiatives show a focus on strategic growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Integer Holdings Corp. Investor Relations
- SEC Filings
- Market Reports
- Financial News Outlets
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary depending on the source. Always consult with a qualified financial advisor before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Integer Holdings Corp
Exchange NYSE | Headquaters Plano, TX, United States | ||
IPO Launch date 2000-09-29 | President, CEO & Director Mr. Joseph W. Dziedzic | ||
Sector Healthcare | Industry Medical Devices | Full time employees 11000 | Website https://www.integer.net |
Full time employees 11000 | Website https://www.integer.net | ||
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.